Back
Cognition Therapeutics Vs. NeuroBo Pharmaceuticals Industry Stock Comparison
Sell
33
CGTX
Cognition Therapeutics
Last Price:
0.43
Seasonality Move:
14.88%
Sell
20
NRBO
NeuroBo Pharmaceuticals
Last Price:
2.40
Seasonality Move:
19.27%
Sell
33
Cognition Therapeutics (CGTX)
is a Sell
Is Cognition Therapeutics a Buy, Sell or Hold?
- The current Cognition Therapeutics [CGTX] share price is $0.44. The Score for CGTX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- CGTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
NeuroBo Pharmaceuticals (NRBO)
is a Sell
Is NeuroBo Pharmaceuticals a Buy, Sell or Hold?
- The current NeuroBo Pharmaceuticals [NRBO] share price is $2.35. The Score for NRBO is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- NRBO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CGTX Stock Price Chart
What is Cognition Therapeutics's stock price today?
-
The Cognition Therapeutics share price today is $0.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CGTX is experiencing slight buying pressure.
NRBO Stock Price Chart
What is NeuroBo Pharmaceuticals's stock price today?
-
The NeuroBo Pharmaceuticals share price today is $2.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRBO is experiencing selling pressure, which indicates risk of future bearish movement.
CGTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 41.18 | Sell |
Chaikin Money Flow: | 158137 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.46 - 0.56) | Sell |
Bollinger Bands (100): | (0.28 - 1.34) | Sell |
NRBO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.14 | Sell |
Relative Strength Index (14 RSI): | 39.46 | Sell |
Chaikin Money Flow: | -9003 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.43 - 2.85) | Sell |
Bollinger Bands (100): | (2.7 - 4.14) | Sell |
CGTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.49 | Sell |
20-day SMA: | 0.5 | Sell |
50-day SMA: | 0.49 | Sell |
200-day SMA: | 1.39 | Sell |
8-day EMA: | 0.47 | Sell |
20-day EMA: | 0.49 | Sell |
50-day EMA: | 0.56 | Sell |
200-day EMA: | 1.15 | Sell |
NRBO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.41 | Sell |
20-day SMA: | 2.58 | Sell |
50-day SMA: | 2.83 | Sell |
200-day SMA: | 3.86 | Sell |
8-day EMA: | 2.42 | Sell |
20-day EMA: | 2.55 | Sell |
50-day EMA: | 2.84 | Sell |
200-day EMA: | 4.72 | Sell |
Cognition Therapeutics Earnings Growth & CGTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.16 per share.
NeuroBo Pharmaceuticals Earnings Growth & NRBO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cognition Therapeutics Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NeuroBo Pharmaceuticals Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |